CLARE OZAWA

Profile

First Name

: CLARE

Middle Name

:

Last Name

: OZAWA

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
INCEPTION IBD, INC.
BRADLEY BOLZON, JEREL DAVIS, PETPIBOON PRASIT, THOMAS WOIWODE
DIRECTOR
MISTRAL THERAPEUTICS, INC.
BRADLEY BOLZON, BRADLEY J BOLZON, JEREMY CALDWELL, THOMAS A COLL, JEREL DAVIS, PETPIBOON PRASIT
DIRECTOR
VERSANT VENTURE CAPITAL VII, L.P.
BRADLEY BOLZON, JEREL DAVIS, ROBIN PRAEGER, N/A VERSANT VENTURES VII GP, L.P., N/A VERSANT VENTURES VII GP-GP, LLC, THOMAS WOIWODE
DIRECTOR
OYSTER POINT PHARMA, INC.
D. MICHAEL ACKERMANN, ALI BEHBAHANI, WILLIAM J LINK, MARK A. MURRAY, JEFFREY NAU, BENJAMIN TSAI
DIRECTOR
858 THERAPEUTICS, INC.
ALI BEHBAHANI, KATHERINE BELL-MCGUINN, BRADLEY J. BOLZON, JANE HUANG, STAFFORD JEFFREY, MONAL MEHTA, CARLO RIZZUTO, JEFFREY A. STAFFORD, JAMES VEAL
DIRECTOR
LYCIA THERAPEUTICS, INC.
TIM ANDERSON, AMY BACHRODT, JEREMY S. CALDWELL, MING FANG, LAURENT FISCHER, ANDREW GOTTESDIENER, WILLIAM RIEFLIN, AETNA WUN TROMBLEY, THOMAS WOIWODE
DIRECTOR
JENGU THERAPEUTICS, INC.
JEREMY CALDWELL, ERIC FISCHER, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VANTAGE II, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, ROBIN PRAEGER, N/A VERSANT VANTAGE II GP, L.P., N/A VERSANT VANTAGE II GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VOYAGEURS II, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, ROBIN PRAEGER, N/A VERSANT VOYAGEURS II GP (CANADA), LLC, N/A VERSANT VOYAGEURS II GP, L.P., N/A VERSANT VOYAGEURS II GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VOYAGEURS II (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, ROBIN PRAEGER, N/A VERSANT VOYAGEURS II GP (CANADA), LLC, N/A VERSANT VOYAGEURS II GP, L.P., N/A VERSANT VOYAGEURS II GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VENTURE CAPITAL VIII, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, ROBIN PRAEGER, N/A VERSANT VENTURES VIII GP (CANADA), LLC, N/A VERSANT VENTURES VIII GP, L.P., N/A VERSANT VENTURES VIII GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, ROBIN PRAEGER, N/A VERSANT VENTURES VIII GP (CANADA), LLC, N/A VERSANT VENTURES VIII GP, L.P., N/A VERSANT VENTURES VIII GP-GP, LLC, THOMAS WOIWODE
DIRECTOR
MARCH THERAPEUTICS, INC.
DANIEL I. DEWOLF, FAHIM FARZADFARD, HABIB HADDAD, JEONG SEUK KANG, ADAM MULLINAX
DIRECTOR
LENZ THERAPEUTICS, INC.
CHRIS DIMITROPOULOS, FRED GUERARD, FREDERIC GUERARD, GERALD HORN, STEFAN LARSON, MARK LESTER, JAMES MCCOLLUM, JAMES W. MCCOLLUM, ZACH SCHEINER, EVERT SCHIMMELPENNINK
EXECUTIVE OFFICER
VERSANT VOYAGEURS III, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CARLO RIZZUTO, N/A VERSANT VOYAGEURS III GP (CANADA), LLC, N/A VERSANT VOYAGEURS III GP, L.P., N/A VERSANT VOYAGEURS III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VOYAGEURS III (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CARLO RIZZUTO, N/A VERSANT VOYAGEURS III GP (CANADA), LLC, N/A VERSANT VOYAGEURS III GP, L.P., N/A VERSANT VOYAGEURS III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VANTAGE III, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CARLO RIZZUTO, N/A VERSANT VANTAGE III GP (CANADA), LLC, N/A VERSANT VANTAGE III GP, L.P., N/A VERSANT VANTAGE III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VANTAGE III (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CARLO RIZZUTO, N/A VERSANT VANTAGE III GP (CANADA), LLC, N/A VERSANT VANTAGE III GP, L.P., N/A VERSANT VANTAGE III GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VENTURE CAPITAL IX, L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CARLO RIZZUTO, N/A VERSANT VENTURES IX GP (CANADA), LLC, N/A VERSANT VENTURES IX GP, L.P., N/A VERSANT VENTURES IX GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VENTURE CAPITAL IX (CANADA), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, CARLO RIZZUTO, N/A VERSANT VENTURES IX GP (CANADA), LLC, N/A VERSANT VENTURES IX GP, L.P., N/A VERSANT VENTURES IX GP-GP, LLC, THOMAS WOIWODE
EXECUTIVE OFFICER
VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
BRADLEY BOLZON, JEREL DAVIS, ALEX MAYWEG, ROBIN PRAEGER, N/A VERSANT VENTURES VII GP, L.P., N/A VERSANT VENTURES VII GP-GP, LLC, THOMAS WOIWODE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-06-10 
2024-07-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-26 
2024-05-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-04-26 
2024-05-09
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2024-04-24 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-04-07
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-10-12 
2023-03-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-06 
2022-11-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-30 
2022-09-23
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-12 
2021-09-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-02 
2021-05-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-04 
2021-04-15
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-11-19 
2021-04-15
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-11-19 
2021-04-15
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-11-19 
2021-04-15
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-11-19 
2021-04-15
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-11-19 
2020-09-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-09 
2020-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-03 
2020-03-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-03 
2019-02-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-15 
2018-12-17
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2018-09-18 
2018-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-12 
2015-12-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-09